Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like 3 Biotechs Leading the Pack in The Hepatitis B Space April 13, 2017 Momenta to Become Neighbors With Biogen, Ironwood in Kendall Square Next Year February 27, 2017 71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite's CAR-T Therapy December 11, 2017
71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite's CAR-T Therapy December 11, 2017
